about
Leaving the lysosome behind: novel developments in autophagy inhibitionCancer beyond organ and tissue specificity: next-generation-sequencing gene mutation data reveal complex genetic similarities across major cancers.Overcoming implementation challenges of personalized cancer therapy.Cancer Systems Biology: a peek into the future of patient care?Targeting therapeutic liabilities engendered by PIK3R1 mutations for cancer treatment.[Mutational tumor profiles beyond organ and tissue specificity: implications for diagnostics and clinical study design].
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
An emerging toolkit for targeted cancer therapies.
@ast
An emerging toolkit for targeted cancer therapies.
@en
type
label
An emerging toolkit for targeted cancer therapies.
@ast
An emerging toolkit for targeted cancer therapies.
@en
prefLabel
An emerging toolkit for targeted cancer therapies.
@ast
An emerging toolkit for targeted cancer therapies.
@en
P2860
P356
P1433
P1476
An emerging toolkit for targeted cancer therapies.
@en
P2093
Gordon B Mills
P2860
P304
P356
10.1101/GR.136044.111
P577
2012-02-01T00:00:00Z